产前精神药物暴露对产科并发症的影响:19年人群研究
宽泛药物类别分析中,暴露组显著关联在阴性对照分析中同样出现,提示可能由未测量混杂因素导致。但亚类分析显示,非典型抗精神病药与泌尿生殖道感染(OR 2.70,95% CI 1.46-4.83)、丙戊酸盐与低出生体重(OR 1.68,95% CI 1.16-2.37)存在显著关联,高E值提示结果不太可能由未测量混杂因素驱动。
要点
- 宽泛类别精神药物孕期暴露与产科并发症无明确因果关联。
- 非典型抗精神病药可能与泌尿生殖道感染风险升高相关。
- 丙戊酸盐可能与低出生体重风险升高相关。
核心结论
- 人群数据与细致分析不支持孕期宽泛类别精神药物暴露与产科/新生儿并发症风险增加存在明确因果关联。
- 某些精神药物亚类可能增加产科/新生儿并发症风险。
研究设计与样本
- 本队列研究纳入2004至2022年香港公立医院所有≥18岁居民的分娩。
- 分娩事件分为未暴露于精神药物、暴露但受孕前已停药、孕期暴露三类。
- 所有分析采用Firth惩罚逻辑回归,并进行阴性对照分析以评估因果性。
- 研究进行了错误发现率校正和敏感性分析。
主要发现
- 宽泛药物类别分析中,暴露组所有显著关联在阴性对照分析(受孕前已停药)中同样观察到。
- 亚类分析中,非典型抗精神病药与泌尿生殖道感染显著关联(OR 2.70,95% CI 1.46-4.83)。
- 亚类分析中,丙戊酸盐与低出生体重显著关联(OR 1.68,95% CI 1.16-2.37)。
- 上述亚类关联在阴性对照分析中变为不显著,但高E值(非典型抗精神病药与泌尿生殖道感染4.84;丙戊酸盐与低出生体重2.75)提示结果不太可能由未测量混杂因素驱动。
关键数值与推荐
- 非典型抗精神病药与泌尿生殖道感染的OR为2.70(95% CI 1.46-4.83)。
- 丙戊酸盐与低出生体重的OR为1.68(95% CI 1.16-2.37)。
- 非典型抗精神病药与泌尿生殖道感染的E值为4.84。
- 丙戊酸盐与低出生体重的E值为2.75。
临床怎么用
- 孕期宽泛类别精神药物暴露未显示明确因果性产科并发症风险,支持继续用药的指南建议。
- 使用非典型抗精神病药或丙戊酸盐时需关注特定产科并发症风险。
- 母亲精神分裂症和抑郁症诊断本身与产科并发症风险增加相关,应加强监测。
局限性
- 某些精神药物亚类停药事件数有限,可能导致阴性对照分析出现假阴性结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although current prescribing guidelines suggest continuation of psychotropic drugs in pregnant women, population-based evidence supporting their safety is limited. AIMS: This study aims to clarify the plausible causal links between maternal psychotropic drug exposures and obstetric complications. METHOD: This cohort study investigated all births by Hong Kong residents ≥18 years of age in public hospitals between 2004 and 2022. Birth episodes were classified according to whether they were unexposed to psychotropic drugs, exposed but discontinued before conception or exposed during pregnancy. Firth's penalised logistic regression was employed in all analysis, and negative control analysis was conducted to assess causality. False discovery rate correction and sensitivity analyses were performed. RESULTS: Among 587 419 births, 7182 episodes involved psychotropic prescriptions (antipsychotics, antidepressants, anticonvulsants, benzodiazepines) during pregnancy. In broad drug class analysis, all significant associations observed in the exposed group were also observed in negative control analysis (psychotropics discontinued before conception), suggesting that elevated risks could be attributed to unmeasured confounders. Nevertheless, in subclass analyses, certain psychotropic drugs showed increased risks of obstetric complications, i.e. significant associations between atypical antipsychotics and genito-urinary infection (odds ratio 2.70, 95% CI 1.46-4.83), and between valproate and low birth weight (odds ratio 1.68, 95% CI 1.16-2.37). These associations became non-significant in negative control analysis, and the high E-values (atypical antipsychotics and genito-urinary infection, 4.84; valproate and low birth weight, 2.75) suggested that the results were unlikely to have been driven by unmeasured confounders. Maternal diagnoses of schizophrenia and depression were independently associated with increased risk of obstetric complications, after controlling for the effects of psychotropics. CONCLUSIONS: The population-based data and meticulous analyses did not support any clear causal link between broad-class psychotropic exposure during pregnancy and increased risk of obstetric/neonatal complications. However, some psychotropic subclasses may increase obstetric/neonatal complications. The limited number of episodes involving discontinuation of some psychotropic subclasses may have resulted in false negative findings in the negative control analysis.
引用
- Leung PBM, Vassos E, Cheung KW, et al. The effect of prenatal psychotropic drug exposures on obstetric complications: 19-year population-based study. Br J Psychiatry. 2025. PMID: 40908901. doi:10.1192/bjp.2025.10340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。